Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment

NCT04154813 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT04154813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04154813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2020
Completion date
November 30, 2022
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fluoxetine